Hi MG0352. What have you docs said about
the advisability of T supplements after treatment for G9? Also, have you considered a genomics test on your biopsied tissue to evaluate the risk of mets? I wonder about
the advisability of T in general for G9, and especially if there is a risk of micrometastases.
You say there were positive cores on both sides -- wouldn't that have made your initial clinical stage T2c rather than T2b?
Post Edited (DjinTonic) : 1/14/2020 9:31:32 AM (GMT-7)